期刊文献+

EsA对BXSB狼疮性肾炎小鼠作用观察 被引量:2

Effect of Esculentoside A on therapeutic and cytokines secretion of lupus nephritis in BXSB mice
下载PDF
导出
摘要 目的观察商陆皂苷甲(EsA)对BXSB小鼠狼疮性肾炎(LN)的治疗作用及IL-6及TNF-α分泌的影响,探讨EsA对LN的可能作用机制。方法 12周龄雄性BXSB小鼠24只,随机分成模型对照组、EsA低剂量治疗组和EsA高剂量治疗组。腹腔注射每日1次,4周后达治疗终点。结果 EsA能显著降低BXSB小鼠尿蛋白/尿肌酐比值,改善BXSB肾脏病变。结论 EsA对BXSB狼疮性肾炎小鼠具有显著治疗作用,抑制IL-6及TNF-α分泌产生可能参与EsA抗炎机制。 Objective To investigate the effect of Esculentoside A(EsA) on therapeutic and cytokines secretion in BXSB mice and the possible mechanism of EsA in treating lupus nephritis(LN). Methods 24 male BXSB mice at the age of 12 weeks were ran- domly divided into 3 groups., untreated model group, EsA(5 mg ·kg^-1 . d^-1 )-treated model group and EsA(20mg · kg · d^-1 ) treated model group. All mice at the age of 16 weeks were killed to obtain samples. Results EsA administration markedly alleviated urine protein/urine creatinine,improved pathological kidney damage and reduced the serum IL-6 and TNF-α level. Conclusion EsA may play significant roles in the treatment of BXSB mice through modulation on inflammatory cytokines.
出处 《重庆医学》 CAS CSCD 北大核心 2012年第28期2954-2955,2958,I0002,共4页 Chongqing medicine
基金 遵义医学院珠海校区校区科研启动基金资助项目(KY200607)
关键词 商陆皂苷甲 狼疮肾炎 白细胞介素6 肿瘤坏死因子α BXSB小鼠 EsA lupus nephritis interleukin-6 tumor necrosis facter-α BXSB mice
  • 相关文献

参考文献13

  • 1Haywood ME, Rogers NJ, Rose SJ, et al. Dissection of BXSB lupus phenotype using mice congenic for chromo- some 1 demonstrates that separate intervals direct difer- ent aspects of disease[J]. Immunol, 2004,173 (7) : 4277- 4285.
  • 2Hogarth MB, Slingsby J H, Allen P J, et al. Multiple lupus susceptibility loci map to chromosomel in BXSB mice[J]. Immunol, 1998,161(6) :2753-2761.
  • 3Fossati L, Iwamoto M, Merino R, et al. Selective enhancing effect of the Yaa gene on immune responses against self and foreign antigens[J]. Eur Immunol,1995,25(1) ..166-173.
  • 4Cheung YH, Loh C, Pau E,et al. Insights into the genetic basis and immunopathogenesis of systemic lupus erythe- matosus from the study of mouse models[J]. Semin Im- munol, 2009,21(6) :372-382.
  • 5张克非,张亮,吴雄飞,张祥贵,于泓,易杨华,赵士启.商陆皂甙甲治疗大鼠抗-Thy1.1系膜增生性肾炎的实验研究[J].四川大学学报(医学版),2004,35(5):662-664. 被引量:19
  • 6张克非 张亮 吴雄飞 等.商陆皂苷甲与地塞米松对系膜增生性肾炎模型疗效对比.中华中西医临床杂志,2003,3(6):675-677.
  • 7Elmore S. Apoptosis.. a review o programmed cell death [J]. Toxicol Pathol,2007,35(3) 495-516.
  • 8Tait JF. Imaging of apoptosis[J]. J Nucl Med, 2008,49 (13) :1573-1576.
  • 9Xiao ZY,Zheng QY,Zhang JP, et al. Effect of esculento- side a on autoinmmunity in mice and its possible mecha- nisms[J]. Acta Pharmacol Sin,2002,23(7) :638-644.
  • 10Hu Z, Qiu L, Xiao Z, et al. Effects of esculentoside a on autoimmune syndrome induced by Campylobacterjejuni in mice and its modulation on T-lymphocyte proliferation and apoptosis[J]. Int Immunopharmacol, 2010,10 ( 1 ) : 65-71.

二级参考文献39

  • 1鞠佃文,郑钦岳,王洪斌,管孝鞠,方军,易杨华.商陆皂甙甲抑制小鼠巨噬细胞和抗体生成[J].药学学报,1994,29(4):252-255. 被引量:9
  • 2高春芳,高玉祥.青蒿琥酯对系统性红斑狼疮样小鼠模型的影响[J].中华皮肤科杂志,1995,28(1):17-19. 被引量:17
  • 3Brenner BM. The kidney. 5th ed. Philadelphia: Saunders,1996:1498--1516.
  • 4Aderka D, Engelmann H, Maor Y, et al. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J Exp Med 1992;175:323--329.
  • 5Nina J Makhatadze. Tumor necrosis factor locus: genetic organization and biological implications. Human Immunol 1998 ;59 : 571--579.
  • 6Kollias G, Kontoyiannis D. Role of TNF/TNFR in autoimmunity: specific TNF receptor blockade may be advantageous to anti-TNF treatments. Cytokine Growth Factor Reviews 2002 ; 13 : 315--321.
  • 7Albert S, Baldwin JR. The NF-kB and IkB protein: new discoveries and insights. Annu Rev Immunol 1996; 14 : 649--683.
  • 8Barnes PJ, Karin M. Nuclear factor-kB----a pivotal transcription factor in chronic inflammatory diseases. New Engl J Med 1997;336:1066.
  • 9Sergei S Makarov. NF-kB as a therapeutic target in chronic inflammation: recent advances. Molecular Medicine Today 2000; 6: 441--448.
  • 10Kroeger KM, Carville KS, Abraham LJ, et al. The-308 tumor necrosis factor-alpha promoter polymorphism effects transcription[J]. Mol Immunol, 1997,34:391-399.

共引文献80

同被引文献38

  • 1周燕斌,李幼姬,谢灿茂,吴玉红.体外阻断CD134对LN患者外周血单个核细胞T_H1/T_H2细胞因子表达的影响[J].中华微生物学和免疫学杂志,2005,25(11):923-927. 被引量:1
  • 2陈月燕,胡波,王潭枫.狼疮性肾炎患者血清IL-6和sIL-2R水平变化的检测[J].国际内科学杂志,2007,34(12):688-689. 被引量:5
  • 3Adalid-Peralta L,Mathian A,Tran T,et al.Leukocytes and the kidney contribute to interstitial inflammation in lupus nephritis[J].Kidney Int,2008,73(2):172-180.
  • 4Ma J,Yu J,Tao X,et al.The imbalance between regulatory and IL-17-secreting CD4+T cells in lupus patients[J].Clin Rheumatol,2010,29(11):1251-1258.
  • 5Charles N,Hardwick D,Daugas E,et al.Basophils and the T helper2 environment can promote the development of lupus nephritis[J].Nat Med,2010,16(6):701-707.
  • 6Ooi JD,Kitching AR.CD4+Th1 cells are effectors in lupus nephritis-but what are their targets?[J].Kidney Int,2012,82(9):927-929.
  • 7Wong CK,HO CY,Li EK,et al.Elevation of pro-inflammatory cytokine(IL-18,IL-17,IL-12)and TH2 cytokine(IL-4)concentrations in patients with systemic lupus erythematosus[J].Lupus,2000,9(8):589-593.
  • 8Kono DH,Balomenos D,Park MS,et al.Development of lupus in BXSB mice is indepedent of IL-4[J].J Immunol,2000,164(1):38-42.
  • 9Uhm WS,Na K,Song GW,et al.Cytokine balance in kidney tissue from lupus nephritis patients[J].Rheumatology,2003,42(8):935-958.
  • 10Tokano Y,Morimoto S,Kaneko H,et al.Levels of IL-12 in the sera of patients with systemic lupus erythematosus(SLE)-relation to Th1 and Th2 derived cytokines[J].Clin Exp Immunol,1999,116(1):169-173.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部